Track Your Ozempic Protocol

Ozempic is a once-weekly injectable semaglutide approved for type 2 diabetes that is widely used off-label for weight loss.

Generic Name

Semaglutide

Manufacturer

Novo Nordisk

Mechanism

GLP-1 receptor agonist

Approved For

Type 2 diabetes, cardiovascular risk

Typical Weight Loss

10-15%

Dosing Frequency

Once weekly injection

Why Track with DoseCurve?

This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication.